LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 30, 2023 | (Q4)Dec 30, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -2.85%6.38B | -3.65%6.48B | -1.20%6.41B | 0.59%26.64B | -7.06%6.86B | 1.00%6.57B | 2.55%6.72B | 7.34%6.49B | 1.70%26.49B | 10.02%7.38B |
Operating revenue | -2.85%6.38B | -3.65%6.48B | -1.20%6.41B | 0.59%26.64B | -7.06%6.86B | 1.00%6.57B | 2.55%6.72B | 7.34%6.49B | 1.70%26.49B | 10.02%7.38B |
Cost of revenue | -3.18%4.2B | -6.23%4.18B | -4.75%4.17B | -3.53%17.71B | -9.45%4.54B | -7.01%4.34B | -2.41%4.46B | 6.37%4.38B | 5.78%18.36B | 10.34%5.02B |
Gross profit | -2.19%2.19B | 1.46%2.29B | 6.15%2.24B | 9.90%8.93B | -1.99%2.32B | 21.27%2.24B | 13.96%2.26B | 9.43%2.11B | -6.45%8.12B | 9.34%2.36B |
Operating expense | -8.49%819M | 3.15%884M | 7.46%908M | 9.31%3.75B | 2.50%1.15B | 16.84%895M | 12.32%857M | 8.75%845M | 1.75%3.43B | 33.81%1.12B |
Selling and administrative expenses | -8.49%819M | 3.15%884M | 7.46%908M | 9.31%3.75B | 2.50%1.15B | 16.84%895M | 12.32%857M | 8.75%845M | 1.75%3.43B | 33.81%1.12B |
-General and administrative expense | -8.49%819M | 3.15%884M | 7.46%908M | 9.31%3.75B | 2.50%1.15B | 16.84%895M | 12.32%857M | 8.75%845M | 1.75%3.43B | 33.81%1.12B |
Operating profit | 2.01%1.37B | 0.43%1.41B | 5.28%1.34B | 10.33%5.18B | -6.03%1.17B | 24.42%1.34B | 14.99%1.4B | 9.88%1.27B | -11.65%4.7B | -6.11%1.24B |
Net non-operating interest income expense | 0.93%-214M | 2.75%-212M | 4.98%-210M | 2.46%-872M | -4.33%-217M | 2.26%-216M | 4.39%-218M | 6.75%-221M | 56.00%-894M | 65.45%-208M |
Non-operating interest income | 33.33%16M | 70.00%17M | 166.67%16M | 48.15%40M | 33.33%12M | 71.43%12M | 66.67%10M | 20.00%6M | 80.00%27M | 350.00%9M |
Non-operating interest expense | 0.88%230M | 0.44%229M | -0.44%226M | -0.98%912M | 5.53%229M | 0.00%228M | -2.56%228M | -6.20%227M | -55.01%921M | -64.07%217M |
Other net income (expense) | -116.27%-1.44B | -5,971.43%-850M | -2,500.00%-96M | 19.14%-676M | -113.33%-2M | -113.50%-664M | 97.64%-14M | -92.59%4M | 46.92%-836M | 101.21%15M |
Gain on sale of security | 0.00%-5M | 90.00%-1M | -700.00%-12M | -125.00%-14M | 66.67%-1M | 70.59%-5M | -130.30%-10M | -95.35%2M | 273.33%56M | -123.08%-3M |
Special income (charges) | -115.56%-1.43B | -85,200.00%-853M | -7,900.00%-80M | 25.90%-658M | -75.00%6M | -125.17%-662M | 99.84%-1M | -110.00%-1M | 44.15%-888M | 101.91%24M |
-Less:Impairment of capital assets | 115.71%1.43B | --854M | ---- | -27.49%662M | --0 | 125.17%662M | --0 | ---- | -44.12%913M | --0 |
-Gain on sale of business | --1M | 200.00%1M | -7,900.00%-80M | -84.00%4M | -75.00%6M | --0 | -150.00%-1M | 0.00%-1M | -43.18%25M | -27.27%24M |
Other non- operating income (expenses) | -233.33%-4M | 233.33%4M | -233.33%-4M | 0.00%-4M | -16.67%-7M | --3M | -400.00%-3M | 200.00%3M | ---4M | ---6M |
Income before tax | -161.52%-283M | -70.31%348M | -2.09%1.03B | 22.49%3.63B | -9.61%950M | -15.60%460M | 193.73%1.17B | 8.24%1.05B | 73.65%2.97B | 302.12%1.05B |
Income tax | -96.60%7M | 42.53%248M | 5.14%225M | 31.61%787M | 17.68%193M | 87.27%206M | 29.85%174M | 12.63%214M | -12.57%598M | 161.89%164M |
Net income | -214.17%-290M | -89.98%100M | -3.94%804M | 20.19%2.85B | -14.66%757M | -41.61%254M | 276.60%998M | 7.17%837M | 131.25%2.37B | 447.84%887M |
Net income continuous Operations | -214.17%-290M | -89.98%100M | -3.94%804M | 20.19%2.85B | -14.66%757M | -41.61%254M | 276.60%998M | 7.17%837M | 131.25%2.37B | 447.84%887M |
Minority interest income | 0 | 0.00%-2M | 200.00%3M | -280.00%-9M | 0 | -366.67%-8M | -2M | -80.00%1M | -58.33%5M | -250.00%-3M |
Net income attributable to the parent company | -210.69%-290M | -89.80%102M | -4.19%801M | 20.82%2.86B | -14.94%757M | -39.35%262M | 277.36%1B | 7.73%836M | 133.50%2.36B | 446.30%890M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -210.69%-290M | -89.80%102M | -4.19%801M | 20.82%2.86B | -14.94%757M | -39.35%262M | 277.36%1B | 7.73%836M | 133.50%2.36B | 446.30%890M |
Basic earnings per share | -214.29%-0.24 | -90.12%0.08 | -2.94%0.66 | 20.73%2.33 | -15.07%0.62 | -40.00%0.21 | 268.18%0.81 | 7.94%0.68 | 132.53%1.93 | 447.62%0.73 |
Diluted earnings per share | -214.29%-0.24 | -90.12%0.08 | -2.94%0.66 | 20.94%2.31 | -15.28%0.61 | -40.00%0.21 | 285.71%0.81 | 7.94%0.68 | 132.93%1.91 | 442.86%0.72 |
Dividend per share | 0.00%0.4 | 0.00%0.4 | 0.00%0.4 | 0.00%1.6 | 0.00%0.4 | 0.00%0.4 | 0.00%0.4 | 0.00%0.4 | 0.00%1.6 | 0.00%0.4 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |